Cytomegalovirus infections after allogeneic bone marrow transplantation

Reviews of Infectious Diseases

Volumn 12, Issue , 1990, Pages S776-S792

  Winston, Drew J ^a   Ho, Winston G ^a   Champlin, Richard E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; CORTICOSTEROID; GANCICLOVIR; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; INTERFERON; VIDARABINE;

ALLOGENIC BONE MARROW TRANSPLANTATION; CLINICAL FEATURE; CONFERENCE PAPER; CYTOMEGALOVIRUS; CYTOTOXIC T LYMPHOCYTE; DISEASE SEVERITY; DRUG EFFICACY; GRAFT VERSUS HOST REACTION; GRANULOCYTE TRANSFUSION; HUMAN; IMMUNITY; IMMUNOPROPHYLAXIS; INTERSTITIAL PNEUMONIA; INTRAVENOUS DRUG ADMINISTRATION; LUNG LAVAGE; MORBIDITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RISK FACTOR; VIRUS INFECTION;

BONE MARROW TRANSPLANTATION; CYTOMEGALOVIRUS INFECTIONS; HUMAN; PULMONARY FIBROSIS; SUPPORT, U.S. GOV'T, P.H.S.; TRANSPLANTATION, HOMOLOGOUS;

EID: 0025121087     PISSN: 01620886     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/12.Supplement_7.S776     Document Type: Article

References (121)

1. Winston DJ, Gale RP, Meyers DV, Young LS, UCLA Bone Marrow Transplantation Group. Infectious complications of human bone marrow transplantation. Medicine (Baltimore) 1979;58:1–31
2. Winston DJ, Ho WG, Champlin RE, Gale RP. Infectious complications of bone marrow transplantation. Exp Hematol 1984;12:205–15
3. Meyers JD, Atkinson K. Infection in bone marrow transplantation. Clin Hematol 1983;12:791–811
4. Appelbaum FR, Meyers JD, Fefer A, Flournoy N, Cheever MA, Greenberg PD, Hackman R, Thomas ED. Nonbacterial nonfungal pneumonia following marrow transplantation in 100 identical twins. Transplantation 1982;33: 265–8
5. Pecego R, Hill R, Appelbaum FR, Amos D, Buckner CD, Fefer A, Thomas ED. Interstitial pneumonitis following autologous bone marrow transplantation. Transplantation 1986;42:515–7
6. Wingard JR, Sostrin MB, Vriesendorp HM, Mellits ED, Santos GW, Fuller DJ, Braine HG, Yeager AM, Bums WH, Saral R. Interstitial pneumonitis following autologous bone marrow transplantation. Transplantation 1988; 46:61–5
7. Wingard JR, Chen DY-H, Burns WH, Fuller DJ, Braine HG, Yeager AM, Kaiser H, Burke PJ, Graham ML, Santos GW, Saral R. Cytomegalovirus infection after autologous bone marrow transplantation with comparison to infection after allogeneic bone marrow transplantation. Blood 1988;71: 1432–7
8. Neiman PE, Reeves W, Ray G, Flournoy N, Lerner KG, Sale GE, Thomas ED, A prospective analysis of interstitial pneumonia and opportunistic viral infection among recipients of allogeneic bone marrow grafts. J Infect Dis 1977;136:754–67
9. Meyers JD, Flournoy N, Thomas ED. Cytomegalovirus infection and specific cell-mediated immunity after marrow transplant. J Infect Dis 1980;142:816–24
10. Meyers JD, Flournoy N, Thomas ED. Risk factors for cytomegalovirus infection after human marrow transplantation. J Infect Dis 1986;153:478–88
11. Paulin T, Ringden O, Lonnqvist B, Wahren B, Nilsson B. The importance of pre bone marrow transplantation serology in determining subsequent cytomegalovirus infection: analysis of risk factors. Scand J Infect Dis 1986; 18:199–209
12. Miller W, Flynn P, McCullough J, Balfour HHJr., Goldman A, Haake R, McGlave P, Ramsay N, Kersey J. Cytomegalovirus infection after bone marrow transplantation: an association with acute graft–v–host disease. Blood 1986;67:1162–7
13. Wingard JR, Mellits ED, Sostrin MB, Chen DY, Burns WH, Santos GW, Vriesendorp HM, Beschorner WE, Saral R. Interstitial pneumonitis after allogeneic bone marrow transplantation: nine–year experience at a single institution. Medicine (Baltimore) 1988;67:175–86
14. Winston DJ, Huang E-S, Miller M J, Lin C-H, Ho WG, Gale RP, Champlin RE. Molecular epidemiology of cytomegalovirus infections associated with bone marrow transplantation. Ann Intern Med 1985;102:16–20
15. Grundy JE, Super M, Griffiths PD. Reinfection of a seropositive allograft recipient by cytomegalovirus from donor kidney [letter]. Lancet 1986;1:159–60
16. Chou S, Cytomegalovirus infection and reinfection transmitted by heart transplantation. J Infect Dis 1987;155: 1054–6
17. Jordan MC, Shanley JD, Stevens JG. Immunosuppression reactivates and disseminates latent murine cytomegalovirus. J Gen Virol 1977;37:419–23
18. Mayo DR, Armstrong JA, Ho M. Reactivation of murine cytomegalovirus by cyclophosphamide. Nature 1977; 267:721–3
19. Dowling JN, Wu BC, Armstrong JA, Ho M. Enhancement of murine cytomegalovirus infection during graft–vs.–host reaction. J Infect Dis 1977;135:990–4
20. Prince AM, Szmuness W, Millian SJ, Davis DS. A serologic study of cytomegalovirus infections associated with blood transfusions. N Engl J Med 1971;284:1125–31
21. Winston DJ, Ho WG, Howell CL, Miller MJ, Mickey R, Martin WJ, Lin C-H, Gale RP. Cytomegalovirus infections associated with leukocyte transfusions. Ann Intern Med 1980;93:671–5
22. Hersman J, Meyers JD, Thomas ED, Buckner CD, Clift R. The effect of granulocyte transfusions on the incidence of cytomegalovirus infection after allogeneic marrow transplantation. Ann Intern Med 1982;96:149–52
23. Bowden RA, Sayers M, Gleaves CA, Banaji B, Newton B, Meyers JD. Cytomegalovirus–seronegative blood components for the prevention of primary cytomegalovirus infection after marrow transplantation. Considerations for blood banks. Transfusion 1987;27:478–81
24. Bowden RA, Sayers M, Flournoy N, Newton B, Banaji M, Thomas ED, Meyers JD. Cytomegalovirus immune globulin and seronegative blood products to prevent primary cytomegalovirus infection after marrow transplantation. N Engl J Med 1986;314:1006–10
25. Winston DJ, Ho WG, Gale RP, Champlin RE. Treatment and prevention of interstitial pneumonia after bone marrow transplantation. In: Gale RP, Champlin RE, eds. Progress in bone marrow transplantation. New York: Alan R. Liss, 1987:525–44
26. Miller W, McCullough J, Balfour HH, Haake R, Ramsay NKC, Goldman A, Bowman R, Kersey J. Prevention of CMV infection by blood products: a randomized trial [abstract no. K128]. J Cell Biochem 1988;12(Suppl C):93
27. Apperley JF, Goldman JM. Cytomegalovirus: biology, clinical features and methods for diagnosis. Bone Marrow Transplant 1988;3:253–64
28. Rook AH, Interactions of cytomegalovirus with the human immune system. Rev Infect Dis 1988;10(Suppl 3):S460–7
29. Jacobson MA, Mills J. Serious cytomegalovirus disease inthe acquired immunodeficiency syndrome (AIDS): clinical findings, diagnosis, and treatment. Ann Intern Med 1988;108:585–94 Reference [30] was deleted in proof.
30. Dokhelar M-C, Wiels J, Lipinski M, Tetaud C, Devergie A, Gluckman E, Itorsz T. Natural killer cell activity in human marrow recipients: early reappearance of peripheral natural kilier activity in graft–versus–host disease. Transplantation 1981;31:61–5
31. Quinnan GVJr., Kirmani N, Rook AH, Manischewitz JF, Jackson L, Moreschi G, Santos GW, Saral R, Burns WH. Cytotoxic T cells in cytomegalovirus infection: HLA–restricted T–lymphocyte and non–T–lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus infection in bone–marrow–transplant recipients. N Engl J Med 1982;307:7–13
32. Livnat S, SeigneUret M, Storb R, Prentice RL. Analysis of cytotoxic effector cell function in patients with leukemia or aplastic anemia before and after marrow transplantation. J Immunol 1980;124:481–90
33. Bowden RA, Day LM, Amos DE, Meyers JD. Natural cytotoxic activity against cytomegalovirus–infected target cells following marrow transplantation. Transplantation 1987; 44:504–8
34. Levin MJ, Parkman R, Oxman MN, Rappeport JM, Simpson M, Leary PL. Proliferative and interferon responses by peripheral blood mononuclear cells after bone marrow transplantation in humans. Infect Immun 1978;20: 678–84
35. Yeager AS, Grumet FC, Hafleigh EB, Arvin AM, Bradley JS, Prober CG. Prevention of transfusion-acquired cytomegalovirus infections in newborn infants. J Pediatr 1981;98:281–7
36. Simmons RL, Matas AJ, Ratazzi LC, Balfour HHJr., Howard RJ, Najarian JS. Clinical characteristics of the lethal cytomegalovirus infection following renal transplantation. Surgery 1977;82:537–46
37. Zaia JA, Forman SJ, Ting Y-P, Vanderwal-Urbina E, Blume KG. Polypeptide–specific antibody response to human cytomegalovirus after infection in bone marrow transplant recipients. J Infect Dis 1986;153:780–7
38. Araullo-Cruz TP, Ho M, Armstrong JA. Protective effect of early serum from mice after cytomegalovirus infection. Infect Immun 1978;21:840–2
39. Shanley JD, Jordan MC, Stevens JG. Modification by adoptive humoral immunity of murine cytomegalovirus infection. J Infect Dis 1981:143:231–7
40. Shanley JD, Pesanti EL. The relation of viral replication to interstitial pneumonitis in murine cytomegalovirus lung infection. J Infect Dis 1985;151:454–8
41. Rubin RH, Wilson EJ, Barrett LV, Medearis DN. The protective effects of hyperimmune anti–murine cytomegalovirus antiserum against lethal viral challenge: the case for passive–active immunization. Clin Immunol Immuno–pathol 1986;39:151–8
42. Winston DJ, Pollard RB, Ho WG, Gallagher JG, Rasmussen LE, Huang SN-Y, Lin C-H, Gossett TG, Merigan TC, Gale RP. Cytomegalovirus immune plasma in bone marrow transplant recipients. Ann Intern Med 1982;97:11–8
43. Meyers JD, Leszcynski J, Zaia JA, Flournoy N, Newton B, Snydman DR, Wright GG, Levin MJ, Thomas ED. Prevention of cytomegalovirus infection by cytomegalovirus immune globulin after marrow transplantation. Ann Intern Med 1983;98:442–6
44. O’Reilly RJ, Reich L, Gold J, Kirkpatrick D, Dinsmore R, Kapoor N, Condie R. A randomized trial of intravenous hyperimmune globulin for the prevention of cytomegalovirus (CMV) infections following marrow transplantation: preliminary results. Transplant Proc 1983;15:1405–11
45. Kubanek B, Ernst P, Ostendorf P, Schafer U, Wolf H. Preliminary data of a controlled trial of intravenous hyperimmune globulin in the prevention of cytomegalovirus infection in bone marrpw transplant recipients. Transplant Proc 1985;17:468–9
46. Winston DJ, Ho WG, Lin CH, Bartoni K, Budinger MD, Gale RP, Champlin RE. Intravenous immune globulin for prevention of cytomegalovirus infection and interstitial pneumonia after bone marrow transplantation. Ann Intern Med 1987;106:12–8
47. Snydman DR, Werner BG, Heinze-Lacey B, Berardi VP, Tilney NL, Kirkman RL, Milford EL, Cho SI, Bush HLJr., Levey AS, Strom TB, Carpenter CB, Levey RH, Harmon WE, Zimmerman CE2nd, Shapiro ME, Steinman T, LoGerfo F, Idelson B, Schroter GPJ, Levin MJ, Mclver J, Leszczynski J, Grady GF. Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal–transplant recipients. N Engl J Med 1987;317:1049–54
48. Witherspoon RP, Lum LG, Storb R. Immunologic reconstitution after human marrow grafting. Semin Hematol 1984;21:2–10
49. Wimperis JZ, Brenner MK, Prentice HG, Reittie JE, Karayiannis P, Griffiths PD, Hoffbrand AV. Transfer of a functioning humoral immune system in transplantation of T–lymphocyte–depleted bone marrow. Lancet 1986; 1:339–43
50. Saxon A, Mitsuyasu R, Stevens R, Champlin RE, Kimata H, Gale RP. Designed transfer of specific immune responses with bone marrow transplantation. J Clin Invest 1986;78:959–67
51. Grob JP, Grundy JE, Prentice HG, Griffiths PD, Hoffbrand AV, Hughes MD, Tate T, Wimperis JZ, Brenner MK. Immune donors can protect marrow–transplant recipients from severe cytomegalovirus infections. Lancet 1987; 1:774–6
52. Ringden O, Lonnqvist B, Sundberg B. Cytomegalovirus immune bone–marrow donors and interstitial pneumonitis. Lancet 1987;2:105–6
53. Meyers JD, Flournoy N, Thomas ED. Nonbacterial pneumonia after allogeneic marrow transplantation: a review of ten years’ experience. Rev Infect Dis 1982;4:1119–32
54. Wahren B, Gahrton G, Linde A, Ljungman P, Lönnqvist B, Ringdén O, Sundqvist V-A. Transfer and persistence of viral antibody–producing cells in bone marrow transplantation. J Infect Dis 1984;150:358–65
55. McDonald GB, Sharma P, Hackman RC, Meyers JD, Thomas ED. Esophageal infections in immunosuppressed patients after marrow transplantation. Gastroenterology 1985;88:1111–7
56. Spencer GD, Hackman RC, McDonald GB, Amos DE, Cunningham BA, Meyers JD, Thomas ED. A prospective study of unexplained nausea and vomiting after marrow transplantation. Transplantation 1986;42:602–7
57. Gleaves CA, Smith TF, Shuster EA, Pearson GR. Comparison of standard tube and shell vial cell culture techniques for the detection of cytomegalovirus in clinical specimens. J Clin Microbiol 1985;21:217–21
58. Gleaves CA, Reed EC, Hackman RC, Meyers JD. Rapid diagnosis of invasive cytomegalovirus infection by examination of tissue specimens in centrifugation culture. Am J Clin Pathol 1987;88:354–8
59. Panjwani DD, Ball MG, Berry NJ, Wimperis JZ, Blacklock HA, Prentice HG, Hoffbrand AV, Griffiths PD. Viro–logical and serological diagnosis of cytomegalovirus infection in bone marrow allograft recipients. J Med Virol 1985;16:357–65
60. Myerson D, Hackman RC, Nelson JA, Ward DC, McDougall JK. Widespread presence of histologically occult cytomegalovirus. Hum Pathol 1984;15:430–9
61. Weiner RS, Bortin MM, Gale RP, Gluckman E, Kay HEM, Kolb H-J, Hartz AJ, Rimm AA. Interstitial pneumonitis after bone marrow transplantation. Assessment of risk factors. Ann Intern Med 1986;104:168–75
62. Weiner RS. Interstitial pneumonia following bone marrow transplantation. In: Gale RP, Champlin RE, eds. Progress in bone marrow transplantation. New York: Alan R. Liss, 1987:507–23
63. Meyers JD, Flournoy N, Wade JC, Hackman RC, McDougall JK, Neiman PE, Thomas ED. Biology of interstitial pneumonia after marrow transplantation. In: Gale RP, ed. Recent advances in bone marrow transplantation. New York: Alan R. Liss, 1983:405–23
64. Winston DJ, Territo MC, Ho WG, Miller MJ, Gale RP, Golde DW. Alveolar macrophage dysfunction in human bone marrow transplant recipients. Am J Med 1982; 73:859–66
65. Grundy JE, Shanley JD, Shearer GM. Augmentation of graft–versus–host reaction by cytomegalovirus infection resulting in interstitial pneumonitis. Transplantation 1985;39:548–53
66. Shanley JD, Pomeroy C, Via CS, Shearer GM. Interstitial pneumonitis during murine cytomegalovirus infection and graft–versus–host reaction: effect of ganciclovir therapy. J Infect Dis 1988;158:1391–4
67. Shepp DH, Dandliker PS, de Miranda P, Burnette TC, Cederberg DM, Kirk LE, Meyers JD. Activity of 9–[2–hydroxy–1–(hydroxlmethyl)ethoxymethyli guanine in the treatment of cytomegalovirus pneumonia. Ann Intern Med 1985;103:368–73
68. Winston DJ, Ho WG, Bartoni K, Holland GN, Mitsuyasu RT, Gale RP, Busuttil RW, Champlin RE. Ganciclovir therapy for cytomegalovirus infections in recipients of bone marrow transplants and other immunosuppressed patients. Rev infect Dis 1988;10(Suppl 3):S547–53
69. Emanuel D, Cunningham I, Jules-Elysee K, Brochstein JA, Kerman NA, Laver J, Stover D, White DA, Fels A, Polsky B, Castro-Malaspina H, Peppard JR, Bartus P, Hammerling U, O’Reilly RJ. Cytomegalovirus pneumonia after bone marrow transplantation successfully treated with the combination of ganciclovir and high–dose intravenous immune globulin. Ann Intern Med 1988;109:777–82
70. Reed EC, Bowden RA, Dandliker PS, Lilleby KE, Meyers JD. Treatment of cytomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants. Ann Intern Med 1988;109:783–8
71. Grundy JE, Shanley JD, Griffiths PD. Is cytomegalovirus interstitial pneumonia in transplant recipients an immunopathological condition? Lancet 1987;2:996–9
72. Bowden RA, Dobbs S, Kopecky KJ, Crawford S, Meyers JD. Increased cytotoxicity against cytomegalovirus–infected target cells by bronchoalveolar lavage cells from bone marrow transplant recipients with cytomegalovirus pneumonia. J Infect Dis 1988;158:773–9
73. Shanley JD, Via CS, Sharrow SO, Shearer GM. Interstitial pneumonitis during murine cytomegalovirus infection and graft–versus–host reaction. Characterization of bronchoalveolar lavage cells. Transplantation 1987;44:658–62
74. Shanley JD, Murine cytomegalovirus pneumonitis in T–cell deficient nude mice [abstract]. In: Abstracts of the 12th Herpesvirus Workshop, Philadelphia, 1987
75. Shanley JD, Pesanti EL, Nugent KM. The pathogenesis of pneumonitis due to murine cytomegalovirus. J Infect Dis 1982;146:388–96
76. Wingard JR, Santos GW, Saral R. Late–onset interstitial pneumonia following allogeneic bone marrow transplant. Transplantation 1985;39:21–3
77. Beschorner WE, Hutchins GM, Burns WH, Saral R, Tutschka PJ, Santos GW. Cytomegalovirus pneumonia in bone marrow transplant recipients: miliary and diffuse patterns. Am Rev Respir Dis 1980;122:107–14
78. Bryson YJ, Jordan MC, Winston DJ, Coloma L, Gale RP. Prospective study of viral infections and interstitial pneumonia in bone marrow transplant recipients [abstract], Clin Res 1980;28:111A
79. Zaia JA, Forman SJ, Gallagher MT, Vanderwal-Urbina E, Blume KG. Prolonged human cytomegalovirus viremia following bone marrow transplantation. Transplantation 1984;37:315–7
80. Schmidt GM, Zaia J, Horak D, Kovacs A, Hawkins G, Nademanee A, O’Donnell MR, Snyder DS, Stein AS, Parker PM, Hill R, Blume KG, Forman SJ. Human cytomegalovirus (HCMV) detection in routine bronchoalveolar lavage (BAL) specimen as a predictor for interstitial pneumonia (IP) in allogeneic bone marrow transplant (BMT) recipients [abstract no. 1531], Blood 1988;72(Suppl 1):405A
81. Springmeyer SC, Silvestri RC, Sale GE, Peterson DL, Weems CE, Huseby JS, Hudson LD, Thomas ED. The role of transbronchial biopsy for the diagnosis of diffuse pneumonias in immunocompromised marrow transplant recipients. Am Rev Respir Dis 1982;126:763–5
82. Miller MJ, Rapid diagnosis of pulmonary cytomegaloviral infection [abstract no. C–294]. In: Abstracts of the Annual Meeting of the American Society for Microbiology. Washington, DC: American Society for Microbiology, 1986
83. Emanuel D, Peppard J, Stover D, Gold J, Armstrong D, Hammerling U. Rapid immunodiagnosis of cytomegalovirus pneumonia by bronchoalveolar lavage using human and murine monoclonal antibodies. Ann Intern Med 1986;104:476–81
84. Cordonnier C, Escudier E, Nicolas J-C, Fleury J, Deforges L, Ingrand D, Bricout F, Bernaudin J-F. Evaluation of three assays on alveolar lavage fluid in the diagnosis of cytomegalovirus pneumonitis after bone marrow transplantation. J Infect Dis 1987;155:495–500
85. Crawford SW, Bowden RA, Hackman RC, Gleaves CA, Meyers JD, Clark JG. Rapid detection of cytomegalovirus pulmonary infection oy bronchoalveolar lavage and centrifugation culture. Ann Intern Med 1988;108:180–5
86. Gleaves CA, Myerson D, Bowden RA, Hackman RC, Meyers JD. Direct detection of cy tomegalovirus from bronchoalveolar lavage using a rapid in situ DNA hybridization assay compared to centrifugation culture [abstract no. 808], In: Program and abstracts of the 28th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology, 1988
87. Myerson D, Hackman RC, Meyers JD, Diagnosis of cytomegaloviral pneumonia by in situ hybridization. J Infect Dis 1984;150:272–7
88. Hackman RC, Myerson D, Meyers JD, Shulman HM, Sale GE, Goldstein LC, Rastetter M, Flournoy N, Thomas ED. Rapid diagnosis of cytomegaloviral pneumonia by tissue immunofluorescence with a murine monoclonal antibody. J Infect Dis 1985;151:325–9
89. Winston DJ, Ho WG, Gale RP, Champlin RE. Prevention and treatment of infections after bone marrow transplantation. In: Baum SJ, Santos GW, Takaku F, eds. Experimental hematology today—1987. Recent advances and future directions in bone marrow transplantation. New York: Springer–Verlag, 1987:177–86
90. Kraemer KG, Neiman PE, Reeves WC, Thomas ED. Prophylactic adenine arabinoside following marrow transplantation. Transplant Proc 1978;10:237–40
91. Meyers JD, McGuffin RW, Neiman PE, Singer JW, Thomas ED. Toxicity and efficacy of human leukocyte interferon for treatment of cytomegalovirus pneumonia after marrow transplantation. J Infect Dis 1980;141:555–62
92. Meyers JD, McGuffin RW, Bryson YJ, Cantell K, Thomas ED. Treatment of cytomegalovirus pneumonia after marrow transplant with combined vidarabine and human leukocyte interferon. J Infect Dis 1982;146:80–4
93. Wade JC, Hintz M, McGuffin RW, Springmeyer SC, Conner JD, Meyers JD. Treatment of cytomegalovirus pneumonia with high–dose acyclovir. Am J Med 1982;73(Suppl A):249–56
94. Wade JC, McGuffin RW, Springmeyer SC, Newton B, Singer JW, Meyers JD. Treatment of cytomegaloviral pneumonia with high–dose acyclovir and human leukocyte interferon. J Infect Dis 1983;148:557–62
95. Winston DJ, Ho WG, Schroff RW, Champlin RE, Gale RP. Safety and tolerance of recombinant leukocyte A interferon in bone marrow transplant recipients. Antimicrob Agents Chemother 1983;23:846–51
96. Meyers JD, Day LM, Lum LG, Sullivan KM. Recombinant leukocyte A interferon for the treatment of serious viral infections after marrow transplant: a phase I study. J Infect Dis 1983;148:551–6
97. Shepp DH, Newton BA, Meyers JD. Intravenous lymphoblastoid interferon and acyclovir for treatment of cytomegalovirus pneumonia. J Infect Dis 1984;150:776–7
98. Ringden O, Lonnqvist B, Paulin T, Ljungman P, Wahren B, Lernestedt J-O. A pilot trial using foscarnet for cytomegalovirus infections in marrow transplant recipients. In: Gale RP, Champlin RE, eds. Progress in bone marrow transplantation. New York: Alan R. Liss, 1987:589–93
99. Erice A, Jordan MC, Chace BA, Fletcher C, Chinnock BJ, Balfour HHJr. Ganciclovir treatment of cytomegalovirus disease in transplant recipients and other immunocompromised hosts. JAMA 1987;257:3082–7
100. Reed EC, Dandliker PS, Meyers JD. Treatment of cytomegalovirus pneumonia with 9–[2–hydroxy–1–(hydroxymethyl)–ethoxymethyl]guanine and high–dose corticosteroids. Ann Intern Med 1986;105:214–5
101. Griffiths PD, Stirk PR, Blacklock HA, Milburn HJ, DuBois RM, Prentice HG. Rapid diagnosis and treatment of cytomegalovirus pneumonitis. In: Gale PR, Champlin RE, eds. Progress in bone marrow transplantation. New York: Alan R. Liss, 1987:583–7
102. Reed EC, Bowden RA, Dandliker PS, Gleaves CA, Meyers JD. Efficacy of cytomegalovirus immunoglobulin in marrow transplant recipients with cytomegalovirus pneumonia. J Infect Dis 1987;156:641–5
103. Cheng Y-C, Huang E-S, Lin J-C, Mar E-C, Pagano JS, Dutschman GE, Grill SP. Unique spectrum of activity of 9[(1,3–dihydroxy–2–propoxy)methyl] guanine against herpesviruses in vitro and its mode of action against herpes simplex virus type 1. Proc Natl Acad Sci USA 1983; 80:2767–70
104. Biron KK, Stanat SC, Sorrell JB, Fyfe JA, Keller PM, Lambe CU, Nelson DJ. Metabolic activation of the nucleoside analogue 9–([2–hydroxy–1–(hydroxymethyl)ethoxy]methyl)–guanine in human diploid fibroblasts infected with human cytomegalovirus. Proc Natl Acad Sci USA 1985; 82:2473–7
105. Tyms AS, Davis JM, Jeffries DJ, Meyers JD. BWB759U, an analogue of acyclovir, inhibits human cytomegalovirus in vitro. Lancet 1984;2:924–5
106. Winston DJ, Ho WG, Champlin RE. Use of DHPG (ganciclovir) and intravenous immune globulin in bone marrow transplants. In: Gale RP, Champlin RE, eds. Bone marrow transplantation: current controversies. New York: Alan R. Liss, 1989:533–51
107. Bratanow NC, Ash RC, Turner PA, Smith R, Haasler G, Chitambar C, Hansen R, Casper J. Successful treatment of serious cytomegalovirus (CMV) disease with 9(1,3– dihydroxy–2–propoxymethyl)guanine (ganciclovir, DHPG) and intravenous immunoglobulin (IVIG) in bone marrow transplant (BMT) patients [abstract no. 254], Exp Hematol 1987;15:541
108. Kovacs A, Schmidt GM, Horak DA, Forman SJ, Zaia JA. Ganciclovir plus intravenous immunoglobulin treatment of human cytomegalovirus interstitial pneumonia in recipients of allogeneic bone marrow transplantation [abstract no. 738], In: Program and abstracts of the 28th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology, 1988
109. Wilson EJ, Medearis DN, Hansen LA, Rubin RH. 9–(1–3–dihydroxy–2–propoxymethyl)guanine prevents death but not immunity in murine cytomegalovirus–infected normal and immunosuppressed BALB/c mice. Antimicrob Agents Chemother 1987;31:1017–20
110. Reed EC, Shepp DH, Dandliker PS, Meyers JD. Ganciclovir treatment of cytomegalovirus infection of the gastrointestinal tract after marrow transplantation. Bone Marrow Transplant 1988;3:199–206
111. Winston DJ, Ho WG, Gale RP, Champlin RE. Prophylaxis of infection in bone marrow transplants. Eur J Cancer Clin Oncol 1988;24(Suppl 1):S15–23
112. Ringden O, Pihlstedt P, Volin L, Nikoskelainen J, Lonnqvist B, Ruutu P, Ruutu T, Toivanen A, Wahren B. Failure to prevent cytomegalovirus infection by cytomegalovirus hyperimmune plasma: a randomized trial by the Nordic Bone Marrow Transplantation Group. Bone Marrow Transplant 1987;2:299–305
113. Peterson FB, Bowden RA, Thornquist M, Meyers JD, Buckner CD, Counts GW, Nelson N, Newton BA, Sullivan KM, Mclver J, Thomas ED. The effect of prophylactic intravenous immune globulin on the incidence of septicemia in marrow transplant recipients. Bone Marrow Thmsplant 1987;2:141–7
114. Sullivan KM, Kopecky K, Jocom J, Buckner CD, Counts G, Meyers JD, Witherspoon RP, Storb R, Thomas ED. Antimicrobial and immunomodulatory effects of intravenous immunoglobulin in bone marrow transplantation [abstract no. 609]. In: Program and abstracts of the 28th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology, 1988
115. Meyers JD, Flournoy N, Sanders JE, McGuffin RW, Newton BA, Fisher LD, Lum LG, Appelbaum FR, Doney K, Sullivan KM, Storb R, Buckner CD, Thomas ED. Prophylactic use of human leukocyte interferon after allogeneic marrow transplantation. Ann Intern Med 1987; 107:809–16
116. Saral R, Burns WH, Laskin OL, Santos GW, Lietman PS. Acyclovir prophylaxis of herpes–simplex–virus infections: a randomized, double–blind, controlled trial in bone–marrow–transplant recipients. N Engl J Med 1981;305: 63–7
117. Wade JC, Newton B, Flournoy N, Meyers JD. Oral acyclovir for prevention of herpes simplex virus reactivation after marrow transplantation. Ann Intern Med 1984;100:823–8
118. Meyers JD, Reed EC, Shepp DH, Thornquist M, Dandliker PS, Vicary CA, Flournoy N, Kirk LE, Kersey JH, Thomas ED, Balfour HHJr. Acyclovir for prevention of cytomegalovirus infection and disease after allogeneic marrow transplantation. N Engl J Med 1988;318:70–5
119. Spector SA, Connor JD, Hintz M, Large K, McMillan R, Higginbottom P. Acyclovir treatment of varicella zoster virus infections complicated by cytomegalovirus pneumonia in bone marrow transplant patients [abstract no. 188]. In: Program and abstracts of the 22nd Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology, 1982
120. Appelbaum FR, Meyers JD, Deeg HJ, Graham T, Schuening F, Storb R. Toxicity trial of prophylactic 9–[2–hydroxy–1–(hydroxymethyl)ethoxymethyl]guanine (ganciclovir) after marrow transplantation in dogs. Antimicrob Agents Chemother 1988;32:271–3
121. Plotkin SA, Gonczol E, Starr SE. Subunit/vaccine against human cytomegalovirus [abstract no. 735], In: Program and abstracts of the 28th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology, 1988